A key investor group in Ethiopia's sole international bond said on Monday it planned to take legal action after the country's ...
Zaha Hadid Architects has revealed plans for the largest airport in Africa. As you might expect from one of the world's most ...
Objectives Maternal dietary practices are vital for improving maternal and neonatal outcomes. However, comprehensive ...
The capital of my home country, and the location of my new restaurant, Marcus Addis Restaurant & Sky Bar, is both the center ...
As Ethiopia implements Digital Ethiopia 2030, the swift deployment of digital platforms, the expansion of e-services, the growth of fintech, and the rollout of the national digital ID registration ...
AMEA Power advances talks on $620 million wind project after high-level meetings 300 MW wind farm planned in Somali region, with output of about 1,400 GWh a year Project backed by power purchase deal ...
More than 20 million people were affected by the 10 largest healthcare data breaches reported to the federal government in 2025, TechTarget reported Dec. 22, citing information from the HHS Office for ...
The benchmark 10-year Treasury yield moved lower on Thursday as investors digested delayed inflation data that showed cooling price pressures. The yield on the 10-year Treasury fell more than 3 basis ...
Blue Owl Capital‘s (NYSE: OWL) decision to step away from financing an Oracle-backed (NYSE: ORCL) AI data center has become a fresh flashpoint for investors already on edge about the financial ...
Structure Therapeutics’ stock soared toward an 18-month high in early Monday trading, after mid-stage data for its oral daily GLP-1 receptor appeared comparable to that of one of Eli Lilly’s ...
Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...
SAN FRANCISCO, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic ...